|
SYNTHES GMBH 9MM/125 DEG TI CANN TFNA 280MM/LEFT - STERILE; ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES
|
Back to Search Results |
|
| Catalog Number |
04.037.919S |
| Medical Device Problem Code |
Break (1069)
|
| Health Effect - Clinical Code |
Insufficient Information (4580)
|
| Date of Event |
11/29/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H10 additional narrative: d9: complainant part is not expected to be returned for manufacturer review/investigation.H3, h6: the investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Event or Problem Description
|
|
Device report from japan reports an event as follows: it was reported that on (b)(6) 2023 the patient underwent the primary surgery with the tfna long nail for a femoral subtrochanteric fracture.The surgery was completed successfully with no surgical delay.After the primary surgery, the nail broke.A bha revision was performed on (b)(6) 2023 and completed successfully.The cause of the nail breakage is unknown, no falls occurred.No further information is available.This report is for a 9mm/125 deg ti cann tfna 280mm/left ¿ sterile.This is report 1 of 1 for (b)(4).
|
| |
|
Additional Manufacturer Narrative
|
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.Manufacturing location: monument, manufacturing date: 10-may-2023, expiration date: 01-may-2033, part number: 04.037.919s, 9mm/125 deg ti cann tfna 280mm/left¿ sterile, lot number: 5957p95 (sterile), lot quantity: (b)(4).Production order traveler met all inspection acceptance criteria.This lot met all dimensional, visual and sterility criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Component part(s) reviewed: part number: 04.037.912.2, lock prong, 125 degree tfna lot number: 6137p66 qty 1 / 6137p62 qty (b)(4), lot quantity: (b)(4).Production order travelers met all inspection acceptance criteria.Part number: 04.037.912.3, tfna lock drive lot number: 5837p16 lot quantity: (b)(4).Production order traveler met all inspection acceptance criteria.Inspection sheet, ns673827 rev a met all inspection acceptance criteria.Part number: 21127, timoagri16.00 lot number: 5646p54 lot quantity: (b)(4).Inspection instruction met all inspection acceptance criteria.Raw material receiving / putaway checklist met all inspection acceptance criteria.Product was not returned.Based on the information available, it has been determined that no corrective and preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.If information is obtained that was not available for this medwatch, a follow-up medwatch will be filed as appropriate.
|
| |
|
Search Alerts/Recalls
|
|
|